biopsy (2 patients with acute renal failure due to acute tubular necrosis), there was concomitant liver disease (1 patient), or they were under 14 years of age at presentation (3 patients). Of the remaining 87 patients those with a definable outcome and sufficient data from time of presentation where selected for study (54 patients).
An outcome value of 0.1 was assigned to those with stable disease (serum creatinine less than 150 mmol/l after 7 years of follow-up). An outcome value of 0.9 was assigned to those with non-stable disease (serum creatinine more than 150 mmol/l after minimum of 2 years follow-up). Seven years was selected as the critical time interval because the renal unit clinical data base has been established for this period. A minimum of 2 years follow-up was required to define outcome as non-stable, as in our experience no patients with serum creatinine >150 mmol/l 2 years after diagnosis improve renal function to serum creatinine <150 mmol/l. Age at time of biopsy, sex, systolic blood pressure, diastolic blood pressure, 24-h urine protein, number of antihypertensive drugs prescribed, and serum creatinine on the day before renal Fig. 1 . Representation of the ANN used to predict the outcomes of biopsy were retrieved from the data base and clinical notes patients with IgAN. of the 54 patients suitable for study to be used as the input variables for the ANN. Table 1 shows the characteristics of this sample of patients. representing 'outcome'. The output of each node is dependent on the inputs and the weights at the connections in the hidden and output layers. The key feature of ANNs is that Training and testing the network the weights at the connections are 'learned' by training the network. 'Experience' in the trained network is stored in The network was trained and evaluated on all cases using a these interconnection weights.
'jack-knife' technique. One case was selected for evaluation Before an ANN is trained, the system begins with random and the network trained on the remaining 53 cases. The weights at the connections between nodes. Data sets with selected case was returned to the training set, the next case known outcome are entered at the input nodes (training data removed for evaluation and the network trained on these 53 set). The ANN compares its own output value with the known cases. The process was repeated for all 54 cases. This outcome and calculates an error value. The error will change technique is useful because it allows all the available cases as the weights at the nodes change. The ANN attempts to to be used in training and gives a meaningful evaluation of minimize the error by adjusting the weights according to a the generalizing ability of the trained networks. The technique known algorithm (back-propagation algorithm). This process does not develop a single trained and validated network. The is repeated hundreds or thousands of times until a desired 'jack-knife' technique has previously been used to evaluate error level is achieved. The ANN can then be tested on a ANNs in medicine such as in predicting malignancy from second group of data sets with known outcome values (test mammograms [6 ] . data set). The performance of the trained ANN is dependent Performance of the ANN was evaluated by calculating the on several logical arguments: at least some of the data variables proportion of predictions correct, and also by calculating must be related to the outcome, the training data sets must sensitivity and specificity values for prediction of non-stable be representative of the population being studied, and the disease. training data must be correct.
Artificial neural networks have several advantages over Comparison with experienced nephrologists
conventional statistical techniques such as multiple regression analysis. They are more flexible for the user, and can solve Six nephrologists from three different centres in the West of non-linear problems.
Scotland were shown the same data from the time of A three-layered neural network was created for this study presentation of the 54 patients described. They were asked using the Neudesk software (Neural Computer Sciences, to predict the outcome, according to the same criteria, Unit 3, Lulworth Business Centre, Nutwood Way, Totton, knowing that the patients had biopsy-proven IgAN, no other Southampton SO40 3WW, UK ) (Figure 1) . After a series of significant renal disease and no concomitant liver disease. trials the network achieved optimum performance with 15 Mean predictive score, sensitivity, and specificity values were hidden nodes and average training error of 0.1.
then calculated and compared with the trained ANN values.
Subjects

Results
The Glasgow Royal Infirmary renal unit data base contains an electronic case record of all patients managed in the unit The output values of the trained network are shown since 1988 and all patients with a diagnosis of IgAN con-in Figure 2 . A decision line at an outcome value of firmed by renal biopsy were identified (99 patients). Patients 0.45 yields optimum performance with a correct predicwere excluded from the study if serum creatinine was tion in 47/54 (87%) cases, with sensitivity of 19/22
>350 mmol/l at presentation (5 patients), there were less (86.4%) and specificity of 28/32 (87.5%). The predictive than five glomeruli per section in the renal biopsy (1 patient), there was more than one cause of renal failure on the renal performance of the experienced nephrologists is shown in Figure 3 . Mean number of predictions correct was to experienced nephrologists, using data collected at 37.5/54 (69.4%, range 35-40), mean sensitivity 72%, the time of diagnosis. and mean specificity 66%. The proportion of correct At present no therapeutic intervention is established predictions by each nephrologist was compared with to prevent or slow progression of renal failure in the proportion of correct predictions by the ANN. The patients with IgAN other than good blood pressure P values for x2 test ranged from 0.007 to 0.089 and control. The outcome to be predicted in our study was the P value was <0.05 in four cases.
defined so as to select a group of patients who we feel The seven cases the ANN predicted incorrectly are merit more intensive follow-up aimed at slowing proshown in Table 2 . All of the experienced nephrologists gression of renal failure. The high-risk patients identiagreed with the incorrect prediction in three of these fied benefit from intensive follow-up to ensure good cases and all of the nephrologists correctly predicted blood pressure control but might also benefit from only two of these cases. new therapeutic developments. One of the main purposes of the study was to demonstrate the potential application of artificial Discussion neural networks to clinical nephrology. One of the difficulties in using ANNs to model the complex relationships between variables is in trying to interrogate The trained ANN can predict the outcome of patients with IgAN with accuracy which is at least equivalent the trained model to define these relationships and outcome in patients with IgAN more accurately than We could anticipate that the performance of an experienced nephrologists using simple retrospective ANN would be improved by including additional data data. A prospective study is required to demonstrate such as measures of blood pressure control during that artificial neural networks can be used as an aid to follow-up and time averaged quantitative proteinuria clinical practice. This should be done by training and as well as quantitative information about tubulointer-testing an ANN on retrospective data and validating stitial disease and glomerulosclerosis on the renal the generalizing ability of that ANN on prospective biopsy. A small proportion of patients with IgAN data as the 'jack-knife' technique does not allow develremain stable for more than 7 years and still develop opment of a single trained and tested model. progressive disease. Studies of ANN to predict 10-, 15-Interrogation of this model would allow insight into and 20-year outcome would be of value and would the relative importance of each variable and the interrequire data from more than one centre to provide actions that might exist between variables in determining the outcome of IgA nephropathy. sufficient training data.
